|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/513 | |||
| A61P 35/02 |
| (11) | Patento numeris | 2978439 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14717212.6 |
| Europos patento paraiškos padavimo data | 2014-03-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2014/050303 |
| Data | 2014-03-19 |
| (87) | Numeris | WO 2014/155376 |
| Data | 2014-10-02 |
| (30) | Numeris | Data | Šalis |
| 201361804677 P | 2013-03-24 | US |
| (72) |
PELED, Amnon, IL
PEREG, Yaron, IL
|
| (73) |
Biokine Therapeutics Ltd.,
Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona,
IL
BIOLINERX LTD., 2 HaMaayan Street, 7177871 Modiln, IL |
| (54) | A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA |
| A COMBINATION OF A CXCR4 ANTAGONIST AND CYTARABINE FOR USE IN TREATING MYELOID LEUKEMIA |